Renaissance Technologies LLC increased its stake in Seer, Inc. (NASDAQ:SEER - Free Report) by 27.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 843,700 shares of the company's stock after purchasing an additional 179,568 shares during the quarter. Renaissance Technologies LLC owned 1.43% of Seer worth $1,949,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Geode Capital Management LLC boosted its holdings in Seer by 5.9% in the third quarter. Geode Capital Management LLC now owns 446,329 shares of the company's stock worth $879,000 after purchasing an additional 25,002 shares during the last quarter. Peapod Lane Capital LLC purchased a new stake in Seer in the fourth quarter worth approximately $991,000. JPMorgan Chase & Co. boosted its stake in shares of Seer by 67.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 175,354 shares of the company's stock worth $345,000 after acquiring an additional 70,671 shares during the last quarter. Barclays PLC boosted its stake in shares of Seer by 34.1% during the 3rd quarter. Barclays PLC now owns 64,426 shares of the company's stock worth $127,000 after acquiring an additional 16,382 shares during the last quarter. Finally, Corient Private Wealth LLC boosted its stake in shares of Seer by 66.0% during the 4th quarter. Corient Private Wealth LLC now owns 33,200 shares of the company's stock worth $77,000 after acquiring an additional 13,200 shares during the last quarter. Hedge funds and other institutional investors own 75.20% of the company's stock.
Seer Stock Performance
Shares of Seer stock traded down $0.01 on Monday, hitting $1.96. 119,855 shares of the company's stock were exchanged, compared to its average volume of 342,169. The company has a 50-day simple moving average of $1.96 and a 200-day simple moving average of $2.17. The stock has a market capitalization of $117.17 million, a PE ratio of -1.51 and a beta of 1.61. Seer, Inc. has a 1 year low of $1.56 and a 1 year high of $2.63.
Seer Profile
(
Free Report)
Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
Read More

Before you consider Seer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Seer wasn't on the list.
While Seer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.